The lack of an Ebola cure amid the deadliest outbreak in the disease’s history is highlighting a significant challenge in the public health world: developing life-saving cures to those who need them the most. In many cases, the Washington Post reports, drug manufacturers don’t have strong enough economic incentives to devote resources to making drugs for populations that would have trouble affording them.